18 February 2019 : Clinical Research
Evaluation of Relationship between Occurrence of Liver Cancer and Methylation of Fragile Histidine Triad (FHIT) and P16 Genes
Yu Bai1C, Yunzhi Shen1AB*, Qiang Yuan1DE, Chengyu Lv1F, Qianzhe Xing1FGDOI: 10.12659/MSM.912315
Med Sci Monit 2019; 25:1301-1306
Abstract
BACKGROUND: We examined the level of fragile histidine triad (FHIT) and p16 gene methylation in patients with hepatocellular carcinoma and explored the relationship to liver cancer.
MATERIAL AND METHODS: There were 56 patients with primary liver cancer who were admitted to the hospital from July 2015 to October 2017 included in the liver cancer group, and 24 non-hepatoma patients (hepatitis A/hepatitis B/hepatitis C, liver cirrhosis, liver fibrosis, and fatty liver, alcoholic liver identified as a control group. Fasting venous blood samples were collected from the 2 groups. Methylation-specific PCR (MSP) was used to detect the methylation of FHIT and p16 genes in the 2 groups. The risk factors for lung cancer were analyzed by logistic regression. In addition, the effects of FHIT and p16 gene methylation on the diagnostic accuracy of liver cancer were calculated.
RESULTS: The incidence of FHIT and p16 methylation in serum from the liver cancer group was 51.8% and 67.9%, respectively. The incidence of FHIT and p16 methylation in the non-hepatoma group was 16.7% and 25.0%. There was a statistical statistically correlated with gender, and the methylation of FHIT and p16 genes (P<0.05). From logistic regression analysis results, methylation of p16 and FHIT genes was an independent risk factor for hepatocellular carcinoma with odds ratio (OR) values of 10.550 (2.313~48.116) and 8.239 (2.386~28.455), respectively.
CONCLUSIONS: The methylation of p16 and FHIT genes was an independent risk factor for hepatocellular carcinoma.
Keywords: Liver Neoplasms, Methylation, Vitamin D-Binding Protein, Acid Anhydride Hydrolases, Biomarkers, Tumor, Carcinoma, Hepatocellular, Case-Control Studies, Cyclin-Dependent Kinase Inhibitor p16, DNA Methylation, Genes, p16, Neoplasm Proteins, Promoter Regions, Genetic, Risk Factors
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
Database Analysis
Long-Term Prognosis of Patients Undergoing Percutaneous Coronary Intervention: The Impact of Serum Creatini...Med Sci Monit In Press; DOI: 10.12659/MSM.943063
Database Analysis
Maternal Exposure to Environmental Air Pollution and Premature Rupture of Membranes: Evidence from Southern...Med Sci Monit In Press; DOI: 10.12659/MSM.943601
Animal Research
Enhanced Bone Healing Through Systemic Capsaicin Administration: An Experimental Study on Wistar RatsMed Sci Monit In Press; DOI: 10.12659/MSM.942485
Clinical Research
Differential Inflammatory Responses in Adult and Pediatric COVID-19 Patients: Implications for Long-Term Co...Med Sci Monit In Press; DOI: 10.12659/MSM.944052
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952